Compare Gilead Sciences, Inc. (GILD) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Unity Software Inc — how do they compare? Gilead Sciences, Inc. trades at $133.16 (market cap $163.51B), while Unity Software Inc trades at $30.81 (market cap $13.65B). The key difference: Gilead Sciences, Inc. is far larger — about 12× Unity Software Inc's market cap, and Gilead Sciences, Inc. pays a 2.49% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals.
| GILD | U | |
|---|---|---|
Market Cap | $163.51B | $13.65B |
Sector | Health | Technology |
52-Week High | $155.80 | $49.47 |
52-Week Low | $108.22 | $17.13 |
Enterprise Value | $178.05B | $13.75B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $130.04, down 1.04% on the day, with technical indicators showing a bearish bias while fundamentals remain strong. The company has beaten earnings expectations for three consecutive quarters, maintains robust profitability with a 30.99% net income margin, and recently secured FDA and European Commission approvals for expanded use of its oncology drug Trodelvy. Analyst consensus remains overwhelmingly positive with a $152.83 price target representing 17.5% upside potential.
The outlook for GILD is favorable with strong earnings momentum, expanding oncology portfolio, and solid cash generation, though risks include patent expirations, competitive pressures in HIV treatments, and recent negative cash flow trends. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharmaceutical company with growth catalysts, supported by Wall Street's bullish sentiment and recent regulatory wins.
Unity Software (U) trades at $31.75, up 3.49% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue of $1.85B in 2025 and a narrowing net loss margin from -66.22% in 2022 to -21.78% in 2025. Positive cash flow from operations reached $423M in 2025, while analyst consensus remains strongly bullish with 18 buy ratings and a $36.50 price target representing 15% upside. Recent news highlights AI integration and advertising technology initiatives as growth drivers.
The outlook balances strong analyst support and improving financial trends against persistent profitability challenges. Investment opportunity centers on Unity's strategic AI pivot and potential margin expansion, while risks include continued net losses, high valuation multiples (EV/EBITDA 134.62), and execution risks in transforming the business model amid gaming industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
